# ClinicalTrials.gov record history: NCT03965130

- Peptide profile: [glucagon](https://peptidescanner.com/peptides/glucagon/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct03965130-glucagon/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/trials/nct03965130.json
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `94caaa0c740d07677c69671156386878f8957091ceec5b05924593bc293d44ce`

## Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

## Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2019-05-24 | 2019-05-24 | RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=1&tab=history) | `ea66cf4474bf1c5eb8bfa1674b7dddbf890de076c939b47e6f6fb3f24c5c27e6` |
| 2 | 2019-05-24 | 2019-05-24 | RECRUITING | INTERVENTIONAL | Eligibility, Study Description, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=2&tab=history) | `a633a23cd0aacc66ae78bedaa1ac16c918a0d66c2899ec6e818d1aa2c2cbeb56` |
| 3 | 2019-12-13 | 2019-12-13 | COMPLETED | INTERVENTIONAL | Contacts/Locations, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=3&tab=history) | `17b50efd1b43abfa9270afa6c451b07e21c0c4278a8aadebba9ebaae0d1edd8b` |
| 4 | 2020-04-01 | 2020-04-01 | COMPLETED | INTERVENTIONAL | Sponsor/Collaborators, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=4&tab=history) | `597e647570c0336d296fafd42d7995d3ce802506986e6865b1f56bd49a1858d9` |
| 5 | 2020-04-14 | 2020-04-14 | COMPLETED | INTERVENTIONAL | Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=5&tab=history) | `cf20a1afa2e2d9f63606b7f46f4f44e306134211ef54f60319cd652aea8178f4` |
| 6 | 2020-07-17 | 2020-07-17 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=6&tab=history) | `6fe00b529382c96fec7d2263b8b22dc5e062b46b5ee7eb90c599092e22fd14ff` |
| 7 | 2021-05-24 | 2021-05-24 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=7&tab=history) | `3774efe01963ffc4b8b3d4c2d08992ab2da2bbafce8a918b6e1f1e361cdb03e3` |
| 8 | 2021-09-20 | 2021-09-20 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Oversight, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=8&tab=history) | `345872013e592cba77b309ad5fe8469bcfef93407e72d7c5924f594cd9f557e3` |
| 9 | 2022-01-17 | 2022-01-17 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Eligibility, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=9&tab=history) | `712fe3c4127a1a61ac07b8014b69a581b108a72642e814fcbf2013e0edc5c53e` |
| 10 | 2023-02-10 | 2023-02-10 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=10&tab=history) | `7c6c47affd8fffb4c34da4ff2ea4f783276391ee7a7c0794a79e4631b51a4e7d` |
| 11 | 2023-02-14 | 2023-02-14 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=11&tab=history) | `cd34599a20368eeb805f16b1209c5a1254b9c201509a83ff33b95437b19c0dec` |
| 12 | 2023-05-19 | 2023-05-19 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=12&tab=history) | `1063079c7e8360e5d05725359271c5c1e5246947f26c81b4a50958b4ae9cd083` |
| 13 | 2023-08-21 | 2023-08-21 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Eligibility, Study Description, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=13&tab=history) | `0644710b59d5431d774f641c381abd69f225630201d75b73d9a481a53043719c` |
| 14 | 2024-02-09 | 2024-02-09 | ENROLLING_BY_INVITATION | INTERVENTIONAL | Arms and Interventions, Document Section, Oversight, Study Design, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=14&tab=history) | `bc475434033cc78bb6b4d692dfc9cfd1dd7c947e37872f928a3e88849b05932a` |
| 16 | 2024-11-18 | 2024-11-18 | COMPLETED | INTERVENTIONAL | Adverse Events, Arms and Interventions, Baseline Characteristics, Document Section, Eligibility, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, Sponsor/Collaborators, Study Description, Study Design, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03965130?a=16&tab=history) | `da28eb4d1406aedc7509237931397d5d40d32c59d5c88ed762390dc1d3030af2` |
